Related Experiment Video

Updated: Apr 18, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K

Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma

Xingming Jiang1, Ning Ma2, Dayong Wang2

  • 1Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Oncotarget
|January 22, 2015
PubMed

Insights

Metformin, an antidiabetic drug, inhibits cholangiocarcinoma (CCA) growth by arresting the cell cycle. It modulates specific microRNAs (miRNAs) linked to tumor progression and survival, offering a promising treatment strategy for CCA.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Metformin exhibits antineoplastic properties across various cancers.
  • The impact of metformin on cholangiocarcinoma (CCA) remains largely uncharacterized.
  • Understanding metformin's role in CCA is crucial for potential therapeutic applications.

Purpose of the Study:

  • To investigate the effects of metformin on cholangiocarcinoma (CCA) progression.
  • To explore the molecular mechanisms underlying metformin's action in CCA.
  • To assess the prognostic value of specific microRNAs (miRNAs) in CCA patients treated with metformin.

Main Methods:

  • In vitro and in vivo studies to assess metformin's effect on CCA cell cycle and tumor growth.
  • Analysis of miRNA expression profiles (mir124, 182, 27b, let7b, 221, 181a) in response to metformin.
  • Correlation analysis of miRNA expression with clinicopathological characteristics and patient survival.
  • Investigation of Drosha's role in metformin-mediated miRNA regulation.

Main Results:

  • Metformin treatment was associated with improved postoperative survival in CCA patients.
  • Metformin inhibited CCA tumor growth through cell cycle arrest.
  • Metformin modulated the expression of six key miRNAs (mir124, 182, 27b, let7b, 221, 181a), which are dysregulated in CCA.
  • These miRNA expression changes correlated with tumor volume and patient prognosis.
  • Metformin upregulated Drosha, influencing miRNA expression and cell cycle regulation.

Conclusions:

  • Metformin inhibits cholangiocarcinoma growth by regulating Drosha-mediated microRNA expression, leading to cell cycle arrest.
  • The evaluated miRNAs are dysregulated in CCA, promote its genesis, and their modulation by metformin impacts proliferation.
  • These miRNAs serve as potential prognostic biomarkers for CCA patients.
  • Metformin presents a promising therapeutic strategy for cholangiocarcinoma prevention and treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
999
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K